ADHERE-S (NIS Brilique)

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study

NCT04609111 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Follow up of Ticagrelor Treatment Patterns in Chinese Acute Coronary Syndromes Patients

NCT04861363 ·Status: UNKNOWN

RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy

NCT02288260 ·Status: COMPLETED

Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS

NCT02415803 ·Status: UNKNOWN ·Phase: PHASE3

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

NCT04338919 ·Status: UNKNOWN ·Phase: NA

Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice

NCT04568083 ·Status: COMPLETED

Antiplatelet Drug Resistances and Ischemic Events

NCT00501423 ·Status: COMPLETED

A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

NCT04255602 ·Status: RECRUITING ·Phase: PHASE4

ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome

NCT03129867 ·Status: COMPLETED

Ticagrelor Administered as Standard Tablet or Orodispersible Formulation

NCT03822377 ·Status: COMPLETED ·Phase: PHASE3

Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions

NCT05732701 ·Status: RECRUITING ·Phase: NA

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

NCT03560310 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).

NCT03317002 ·Status: COMPLETED ·Phase: PHASE2

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

NCT01952392 ·Status: COMPLETED

Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

NCT04718025 ·Status: UNKNOWN ·Phase: PHASE3

Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage

NCT05986968 ·Status: RECRUITING ·Phase: NA

A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

NCT07318155 ·Status: RECRUITING ·Phase: PHASE2

Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients with Acute Coronary Syndrome in a Real-world Registry

NCT05774431 ·Status: COMPLETED

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

NCT04271280 ·Status: COMPLETED

Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial

NCT06756945 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

NCT01225562 ·Status: COMPLETED ·Phase: PHASE3

Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI

NCT04981041 ·Status: UNKNOWN ·Phase: PHASE4

Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy

NCT02219412 ·Status: COMPLETED ·Phase: PHASE4

Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"

NCT02206815 ·Status: COMPLETED ·Phase: PHASE4

Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data

NCT05086081 ·Status: COMPLETED